rosiglitazone has been researched along with Ischemic Attack, Transient in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J; Wang, LN | 3 |
| Huang, HG; Lin, YH; Lou, M; Sun, JZ; Wen, SQ; Zhang, FH | 1 |
| Fatehi-Hassanabad, Z; Tasker, RA | 1 |
| Byun, K; Choi, JH; Hwang, IK; Kim, YM; Lee, B; Lee, CH; Park, OK; Won, MH; Yoo, KY | 1 |
| Gupta, K; Mishra, V; Raghubir, R; Sasmal, D; Verma, R | 1 |
| Chan, PH; Jung, JE; Kim, GS; Maier, CM; Narasimhan, P; Okami, N; Sakata, H; Yoshioka, H | 1 |
| Chu, K; Jung, KH; Kim, EH; Kim, JM; Kim, M; Kim, SJ; Ko, SY; Koo, JS; Lee, ST; Roh, JK; Sinn, DI; Song, EC | 1 |
| Aronowski, J; Deininger, K; Gamboa, J; Landreth, GE; Lust, WD; Sundararajan, S; Victor, NA; Wanderi, EW; Zhao, X | 1 |
| Chen, SD; Chuang, YC; Lee, SY; Lin, TK; Liou, CW; Shaw, FZ; Wu, HY; Yang, DI | 1 |
| Clancy, P; Golledge, J; Mangan, S | 1 |
| Bowen, KK; Feinstein, DL; Kapadia, R; Liang, J; Satriotomo, I; Tureyen, K; Vemuganti, R | 1 |
3 review(s) available for rosiglitazone and Ischemic Attack, Transient
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
Topics: Cardiovascular Diseases; Carotid Artery Diseases; Humans; Hypoglycemic Agents; Insulin Resistance; Ischemic Attack, Transient; Myocardial Infarction; Pioglitazone; PPAR gamma; Proteasome Endopeptidase Complex; Randomized Controlled Trials as Topic; Recurrence; Rosiglitazone; Secondary Prevention; Stroke; Thiazolidinediones; Ubiquitin | 2017 |
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Topics: Cardiovascular Diseases; Humans; Hypoglycemic Agents; Ischemic Attack, Transient; Myocardial Infarction; Pioglitazone; PPAR gamma; Rosiglitazone; Secondary Prevention; Stroke; Thiazolidinediones | 2014 |
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack.
Topics: Cardiovascular Diseases; Humans; Hypoglycemic Agents; Ischemic Attack, Transient; Myocardial Infarction; Pioglitazone; PPAR gamma; Randomized Controlled Trials as Topic; Rosiglitazone; Secondary Prevention; Stroke; Thiazolidinediones | 2015 |
10 other study(ies) available for rosiglitazone and Ischemic Attack, Transient
| Article | Year |
|---|---|
Rosiglitazone attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal ischemia in rats.
Topics: Animals; Blood Glucose; Collagen Type IV; Glucose Transporter Type 1; Hemoglobins; Hyperglycemia; Hypoglycemic Agents; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2013 |
Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.
Topics: Animals; Disease Models, Animal; Hydrogen Peroxide; Ischemic Attack, Transient; Male; Mice; Neuroprotective Agents; Oxidative Stress; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.
Topics: Animals; Astrocytes; CA1 Region, Hippocampal; Cell Death; Disease Models, Animal; Gerbillinae; Interleukin-13; Interleukin-4; Ischemic Attack, Transient; Male; Microglia; Nerve Degeneration; Neuroprotective Agents; PPAR gamma; Reperfusion; Rosiglitazone; Thiazolidinediones | 2011 |
Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
Topics: Animals; Brain; Excitatory Amino Acid Transporter 2; Fibrinolytic Agents; Glutamate-Ammonia Ligase; Interleukin-1beta; Ischemic Attack, Transient; Male; Motor Activity; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2011 |
Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
Topics: Animals; Blotting, Western; Cell Death; Disease Models, Animal; Dual-Specificity Phosphatases; Enzyme Activation; Glucose; Ischemic Attack, Transient; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxygen; Phosphorylation; PPAR gamma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2013 |
Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.
Topics: Animals; Blotting, Western; Brain; Caspase 3; Caspases; Dose-Response Relationship, Drug; Endothelium, Vascular; Fas Ligand Protein; Image Processing, Computer-Assisted; Immunohistochemistry; Ischemic Attack, Transient; Male; Membrane Glycoproteins; Neovascularization, Physiologic; Neuroprotective Agents; Nitric Oxide Synthase Type III; PPAR gamma; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factors | 2006 |
Altered PPARgamma expression and activation after transient focal ischemia in rats.
Topics: Animals; Benzamides; Enzyme Activation; Gene Expression Regulation; Immunohistochemistry; Ischemic Attack, Transient; Male; PPAR gamma; Protein Binding; Pyridines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2006 |
Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2.
Topics: Animals; Hippocampus; Ion Channels; Ischemic Attack, Transient; Male; Mitochondrial Proteins; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Uncoupling Protein 2 | 2006 |
Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fenofibrate; Humans; Ischemic Attack, Transient; Ligands; Lipoproteins; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR gamma; Rosiglitazone; Signal Transduction; Stroke; Thiazolidinediones; Thromboplastin | 2007 |
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Topics: Anilides; Animals; Cerebral Infarction; Chemotaxis, Leukocyte; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Encephalitis; Hypertension; Intercellular Adhesion Molecule-1; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroprotective Agents; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Superoxide Dismutase-1; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones | 2007 |